Labcorp Debt to Equity Ratio 2010-2025 | LH
Current and historical debt to equity ratio values for Labcorp (LH) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Labcorp debt/equity for the three months ending March 31, 2025 was 0.68.
| Labcorp Debt/Equity Ratio Historical Data |
| Date |
Long Term Debt |
Shareholder's Equity |
Debt to Equity Ratio |
| 2025-03-31 |
$9.30B |
$8.31B |
1.12 |
| 2024-12-31 |
$10.33B |
$8.05B |
1.28 |
| 2024-09-30 |
$10.44B |
$8.17B |
1.28 |
| 2024-06-30 |
$8.71B |
$8.01B |
1.09 |
| 2024-03-31 |
$8.57B |
$7.96B |
1.08 |
| 2023-12-31 |
$8.85B |
$7.88B |
1.12 |
| 2023-09-30 |
$9.01B |
$7.87B |
1.15 |
| 2023-06-30 |
$8.93B |
$8.79B |
1.02 |
| 2023-03-31 |
$9.86B |
$10.34B |
0.95 |
| 2022-12-31 |
$10.06B |
$10.10B |
1.00 |
| 2022-09-30 |
$9.73B |
$10.09B |
0.96 |
| 2022-06-30 |
$10.00B |
$10.40B |
0.96 |
| 2022-03-31 |
$10.01B |
$10.72B |
0.93 |
| 2021-12-31 |
$10.11B |
$10.27B |
0.98 |
| 2021-09-30 |
$10.34B |
$10.53B |
0.98 |
| 2021-06-30 |
$10.17B |
$10.25B |
0.99 |
| 2021-03-31 |
$10.40B |
$10.02B |
1.04 |
| 2020-12-31 |
$10.64B |
$9.44B |
1.13 |
| 2020-09-30 |
$10.50B |
$8.24B |
1.27 |
| 2020-06-30 |
$10.50B |
$7.35B |
1.43 |
| 2020-03-31 |
$10.28B |
$7.02B |
1.46 |
| 2019-12-31 |
$10.48B |
$7.57B |
1.39 |
| 2019-09-30 |
$10.62B |
$7.23B |
1.47 |
| 2019-06-30 |
$10.60B |
$7.14B |
1.48 |
| 2019-03-31 |
$9.86B |
$7.11B |
1.39 |
| 2018-12-31 |
$9.21B |
$6.97B |
1.32 |
| 2018-09-30 |
$9.41B |
$7.25B |
1.30 |
| 2018-06-30 |
$9.47B |
$7.04B |
1.35 |
| 2018-03-31 |
$9.85B |
$6.98B |
1.41 |
| 2017-12-31 |
$9.87B |
$6.80B |
1.45 |
| 2017-09-30 |
$10.57B |
$6.13B |
1.73 |
| 2017-06-30 |
$9.02B |
$5.88B |
1.54 |
| 2017-03-31 |
$8.78B |
$5.65B |
1.55 |
| 2016-12-31 |
$8.74B |
$5.51B |
1.59 |
| 2016-09-30 |
$8.96B |
$5.52B |
1.62 |
| 2016-06-30 |
$8.89B |
$5.31B |
1.67 |
| 2016-03-31 |
$9.24B |
$5.17B |
1.79 |
| 2015-12-31 |
$9.16B |
$4.95B |
1.85 |
| 2015-09-30 |
$9.51B |
$4.91B |
1.94 |
| 2015-06-30 |
$9.70B |
$4.77B |
2.03 |
| 2015-03-31 |
$9.63B |
$4.52B |
2.13 |
| 2014-12-31 |
$4.48B |
$2.82B |
1.59 |
| 2014-09-30 |
$4.46B |
$2.77B |
1.61 |
| 2014-06-30 |
$4.49B |
$2.66B |
1.69 |
| 2014-03-31 |
$4.49B |
$2.50B |
1.80 |
| 2013-12-31 |
$4.48B |
$2.49B |
1.80 |
| 2013-09-30 |
$4.12B |
$2.57B |
1.61 |
| 2013-06-30 |
$3.93B |
$2.66B |
1.48 |
| 2013-03-31 |
$3.79B |
$2.78B |
1.37 |
| 2012-12-31 |
$4.08B |
$2.72B |
1.50 |
| 2012-09-30 |
$4.10B |
$2.72B |
1.51 |
| 2012-06-30 |
$3.47B |
$2.63B |
1.32 |
| 2012-03-31 |
$3.53B |
$2.60B |
1.36 |
| 2011-12-31 |
$3.61B |
$2.50B |
1.44 |
| 2011-09-30 |
$3.51B |
$2.54B |
1.38 |
| 2011-06-30 |
$3.59B |
$2.58B |
1.39 |
| 2011-03-31 |
$3.80B |
$2.40B |
1.58 |
| 2010-12-31 |
$3.72B |
$2.47B |
1.51 |
| 2010-09-30 |
$2.78B |
$2.27B |
1.22 |
| 2010-06-30 |
$2.75B |
$2.21B |
1.25 |
| 2010-03-31 |
$2.78B |
$2.16B |
1.29 |
| 2009-12-31 |
$2.73B |
$2.11B |
1.30 |
| 2009-09-30 |
$2.80B |
$2.03B |
1.38 |
| 2009-06-30 |
$2.70B |
$2.01B |
1.35 |
| 2009-03-31 |
$3.01B |
$1.82B |
1.66 |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical & Dental Supplies |
$20.745B |
$13.009B |
|
Laboratory Corporation of America Holdings or LabCorp is a leading healthcare diagnostics company, providing comprehensive clinical laboratory services and end-to-end drug development support. The provide vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions.
|
